Citation Tools

Download PDFPDF

From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer

Download to a citation manager

Cite this article as:
Pirker R, Filipits M
From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer